Classification and Pathology

Surgical Clinics of North America

Volumn 88, Issue 3, 2008, Pages 483-520

  Wu, Julie M ^a   Montgomery, Elizabeth ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CLINICAL FEATURE; FIBROMA; FIBROMATOSIS; FIBROSARCOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOMA; LIPOSARCOMA; MUSCLE TUMOR; NERVE SHEATH TUMOR; PRIORITY JOURNAL; REVIEW; SOFT TISSUE TUMOR;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FIBROMA; HUMANS; LIPOSARCOMA; LIPOSARCOMA, MYXOID; NERVE SHEATH NEOPLASMS; SARCOMA;

EID: 44449143952     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.03.007     Document Type: Review

References (194)

1. Fletcher C., Unni K., and Mertens F.E. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone (2002), IACR Press, Lyon (France)
2. Weiss S. Histological typing of soft tissue tumours (1994), Springer-Verlag, Berlin
3. Weiss S., and Goldblum J. Enzinger and Weiss's soft tissue tumors. 4th edition (2001), Mosby, St. Louis (MO)
4. Montgomery E., and Aaron A.E. Clinical pathology of soft tissue tumors (2001), Marcel Dekker, New York
5. Costa J., Wesley R.A., Glatstein E., et al. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 53 (1984) 530-541
6. Markhede G., Angervall L., and Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 49 (1982) 1721-1733
7. Myhre-Jensen O., Kaae S., Madsen E.H., et al. Histopathological grading in soft-tissue tumours. Relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scand [A] 91 (1983) 145-150
8. Miettinen M., and Fetsch J.F. Collagenous fibroma (desmoplastic fibroblastoma): a clinicopathologic analysis of 63 cases of a distinctive soft tissue lesion with stellate- shaped fibroblasts. Hum Pathol 29 (1998) 676-682
9. Chung E.B., and Enzinger F.M. Fibroma of tendon sheath. Cancer 44 (1979) 1945-1954
10. Kransdorf M.J., Meis J.M., and Montgomery E. Elastofibroma: MR and CT appearance with radiologic-pathologic correlation. AJR Am J Roentgenol 159 (1992) 575-579
11. Nishio J., Iwasaki H., Ohjimi Y., et al. Gain of Xq detected by comparative genomic hybridization in elastofibroma. Int J Mol Med 10 (2002) 277-280
12. Turna A., Yilmaz M.A., Urer N., et al. Bilateral elastofibroma dorsi. Ann Thorac Surg 73 (2002) 630-632
13. Keasbey L. Juvenile aponeurotic fibroma (calcifying fibroma): a distinctive tumor arising in the palms and soles of young children. Cancer 6 (1953) 338-346
14. Birdsall S.H., Shipley J.M., Summersgill B.M., et al. Cytogenetic findings in a case of nodular fasciitis of the breast. Cancer Genet Cytogenet 81 (1995) 166-168
15. Weibolt V.M., Buresh C.J., Roberts C.A., et al. Involvement of 3q21 in nodular fasciitis. Cancer Genet Cytogenet 106 (1998) 177-179
16. Konwaler B., Keasbey L., and Kaplan L. Subcutaneous pseudosarcomatous fibromatosis (fasciitis). Am J Clin Pathol 25 (1955) 241-252
17. Montgomery E.A., and Meis J.M. Nodular fasciitis. Its morphologic spectrum and immunohistochemical profile. Am J Surg Pathol 15 (1991) 942-948
18. Shimizu S., Hashimoto H., and Enjoji M. Nodular fasciitis: an analysis of 250 patients. Pathology 16 (1984) 161-166
19. Meister P., Buckmann F.W., and Konrad E. Nodular fasciitis (analysis of 100 cases and review of the literature). Pathol Res Pract 162 (1978) 133-165
20. Wirman J.A. Nodular fasciitis, a lesion of myofibroblasts: an ultrastructural study. Cancer 38 (1976) 2378-2389
21. Allen P.W. Nodular fasciitis. Pathology 4 (1972) 9-26
22. Chung E.B., and Enzinger F.M. Proliferative fasciitis. Cancer 36 (1975) 1450-1458
23. Reitamo J.J. The desmoid tumor. IV. Choice of treatment, results, and complications. Arch Surg 118 (1983) 1318-1322
24. Hayry P., Reitamo J.J., Totterman S., et al. The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 77 (1982) 674-680
25. Hayry P., Reitamo J.J., Vihko R., et al. The desmoid tumor. III. A biochemical and genetic analysis. Am J Clin Pathol 77 (1982) 681-685
26. Wilson R.W., Gallateau-Salle F., and Moran C.A. Desmoid tumors of the pleura: a clinicopathologic mimic of localized fibrous tumor. Mod Pathol 12 (1999) 9-14
27. Mehrotra A.K., Sheikh S., Aaron A.D., et al. Fibromatoses of the extremities: clinicopathologic study of 36 cases. J Surg Oncol 74 (2000) 291-296
28. Enzinger F.M., and Shiraki M. Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid). Analysis of thirty cases followed up for ten or more years. Cancer 20 (1967) 1131-1140
29. Haggitt R.C., and Booth J.L. Bilateral fibromatosis of the breast in Gardner's syndrome. Cancer 25 (1970) 161-166
30. Naylor E.W., Gardner E.J., and Richards R.C. Desmoid tumors and mesenteric fibromatosis in Gardner's syndrome: report of kindred 109. Arch Surg 114 (1979) 1181-1185
31. Ayala A.G., Ro J.Y., Goepfert H., et al. Desmoid fibromatosis: a clinicopathologic study of 25 children. Semin Diagn Pathol 3 (1986) 138-150
32. Wargotz E.S., Norris H.J., Austin R.M., et al. Fibromatosis of the breast. A clinical and pathological study of 28 cases. Am J Surg Pathol 11 (1987) 38-45
33. Rosen P.P., and Ernsberger D. Mammary fibromatosis. A benign spindle-cell tumor with significant risk for local recurrence. Cancer 63 (1989) 1363-1369
34. Burke A.P., Sobin L.H., and Shekitka K.M. Mesenteric fibromatosis. A follow-up study. Arch Pathol Lab Med 114 (1990) 832-835
35. Reitamo J.J., Hayry P., Nykyri E., et al. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77 (1982) 665-673
36. Allen P.W. The fibromatoses: a clinicopathologic classification based on 140 cases. Am J Surg Pathol 1 (1977) 255-270
37. Montgomery E., Lee J.H., Abraham S.C., et al. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol 14 (2001) 695-701
38. Abraham S.C., Reynolds C., Lee J.H., et al. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol 33 (2002) 39-46
39. Burke A.P., Sobin L.H., Shekitka K.M., et al. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 14 (1990) 335-341
40. Zayid I. Multicentric fibromatosis of familial inheritance. Arch Pathol Lab Med 112 (1988) 577
41. Zayid I., and Dihmis C. Familial multicentric fibromatosis-desmoids. A report of three cases in a Jordanian family. Cancer 24 (1969) 786-795
42. Harvey J.C., Quan S.H., and Fortner J.G. Gardner's syndrome complicated by mesenteric desmoid tumors. Surgery 85 (1979) 475-477
43. Russell W.O., Cohen J., Enzinger F., et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer 40 (1977) 1562-1570
44. Fisher C. The value of electron microscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 cases. Histopathology 16 (1990) 441-454
45. Fukasawa Y., Takada A., Tateno M., et al. Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II. Pathol Int 48 (1998) 47-52
46. Kotani K., Tsuji M., Oki A., et al. IGF-II producing hepatic fibrosarcoma associated with hypoglycemia. Intern Med 32 (1993) 897-901
47. Scott S.M., Reiman H.M., Pritchard D.J., et al. Soft tissue fibrosarcoma. A clinicopathologic study of 132 cases. Cancer 64 (1989) 925-931
48. Pritchard D.J., Sim F.H., Ivins J.C., et al. Fibrosarcoma of bone and soft tissues of the trunk and extremities. Orthop Clin North Am 8 (1977) 869-881
49. Pritchard D.J., Soule E.H., Taylor W.F., et al. Fibrosarcoma-a clinicopathologic and statistical study of 199 tumors of the soft tissues of the extremities and trunk. Cancer 33 (1974) 888-897
50. Lane K.L., Shannon R.J., and Weiss S.W. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. [see comments]. Am J Surg Pathol 21 (1997) 1481-1488
51. Woodruff J.M., Antonescu C.R., Erlandson R.A., et al. Low-grade fibrosarcoma with palisaded granulomalike bodies (giant rosettes): report of a case that metastasized. Am J Surg Pathol 23 (1999) 1423-1428
52. Folpe A.L., Lane K.L., Paull G., et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. [In Process Citation]. Am J Surg Pathol 24 (2000) 1353-1360
53. Reid R., de Silva M.V., Paterson L., et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol 27 (2003) 1229-1236
54. Goldblum J.R. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Arch Pathol Lab Med 119 (1995) 238-241
55. Abenoza P., and Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 15 (1993) 429-434
56. Lopes J.M., and Paiva M.E. Dermatofibrosarcoma protuberans. A histological and ultrastructural study of 11 cases with emphasis on the study of recurrences and histogenesis. Pathol Res Pract 187 (1991) 806-813
57. Mentzel T., Beham A., Katenkamp D., et al. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol 22 (1998) 576-587
58. Petoin D.S., Verola O., Banzet P., et al. [Darier-Ferrand dermatofibrosarcoma. Study of 96 cases over 15 years]. Chirurgie 111 (1985) 132-138 [in French]
59. Goldblum J.R., and Tuthill R.J. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol 19 (1997) 147-153
60. Weiss S.W., and Nickoloff B.J. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17 (1993) 1039-1045
61. Minoletti F., Miozzo M., Pedeutour F., et al. Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 13 (1995) 62-65
62. Mandahl N., Heim S., Willen H., et al. Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 49 (1990) 273-275
63. O'Brien K.P., Seroussi E., Dal Cin P., et al. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23 (1998) 187-193
64. Simon M.P., Pedeutour F., Sirvent N., et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15 (1997) 95-98
65. Fletcher C.D. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16 (1992) 213-228
66. Cole C.H., Magee J.F., Gianoulis M., et al. Malignant fibrous histiocytoma in childhood. Cancer 71 (1993) 4077-4083
67. Fanburg-Smith J.C., Spiro I.J., Katapuram S.V., et al. Infiltrative subcutaneous malignant fibrous histiocytoma: a comparative study with deep malignant fibrous histiocytoma and an observation of biologic behavior. Ann Diagn Pathol 3 (1999) 1-10
68. Montgomery E., and Fisher C. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathologic study. Histopathology 38 (2001) 499-509
69. Pezzi C.M., Rawlings Jr. M.S., Esgro J.J., et al. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 69 (1992) 2098-2103
70. Le Doussal V., Coindre J.M., Leroux A., et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer 77 (1996) 1823-1830
71. Weiss S.W., and Enzinger F.M. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41 (1978) 2250-2266
72. Mertens F., Fletcher C.D., Dal Cin P., et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and Morphology. Genes Chromosomes Cancer 22 (1998) 16-25
73. Henricks W.H., Chu Y.C., Goldblum J.R., et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 21 (1997) 271-281
74. Guccion J.G., and Enzinger F.M. Malignant giant cell tumor of soft parts. An analysis of 32 cases. Cancer 29 (1972) 1518-1529
75. Merino M.J., and LiVolsi V.A. Inflammatory malignant fibrous histiocytoma. Am J Clin Pathol 73 (1980) 276-281
76. Kyriakos M., and Kempson R.L. Inflammatory fibrous histiocytoma. An aggressive and lethal lesion. Cancer 37 (1976) 1584-1606
77. Coindre J.M., Hostein I., Maire G., et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203 (2004) 822-830
78. Gamez J., Playan A., Andreu A.L., et al. Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA. Neurology 51 (1998) 258-260
79. Ronan S.J., and Broderick T. Minimally invasive approach to familial multiple lipomatosis. Plast Reconstr Surg 106 (2000) 878-880
80. Tsao H., and Sober A.J. Multiple lipomatosis in a patient with familial atypical mole syndrome. Br J Dermatol 139 (1998) 1118-1119
81. Stoll C., Alembik Y., and Truttmann M. Multiple familial lipomatosis with polyneuropathy, an inherited dominant condition. Ann Genet 39 (1996) 193-196
82. Chung E.B., and Enzinger F.M. Benign lipoblastomatosis. An analysis of 35 cases. Cancer 32 (1973) 482-492
83. Hicks J., Dilley A., Patel D., et al. Lipoblastoma and lipoblastomatosis in infancy and childhood: histopathologic, ultrastructural, and cytogenetic features. Ultrastruct Pathol 25 (2001) 321-333
84. Mentzel T., Calonje E., and Fletcher C.D. Lipoblastoma and lipoblastomatosis: a clinicopathological study of 14 cases. Histopathology 23 (1993) 527-533
85. Collins M.H., and Chatten J. Lipoblastoma/lipoblastomatosis: a clinicopathologic study of 25 tumors. Am J Surg Pathol 21 (1997) 1131-1137
86. Dal Cin P., Sciot R., De Wever I., et al. New discriminative chromosomal marker in adipose tissue tumors. The chromosome 8q11-q13 region in lipoblastoma. Cancer Genet Cytogenet 78 (1994) 232-235
87. Howard W.R., and Helwig E.B. Angiolipoma. Arch Dermatol 82 (1960) 924-931
88. Enzinger F.M., and Harvey D.A. Spindle cell lipoma. Cancer 36 (1975) 1852-1859
89. Dal Cin P., Sciot R., Polito P., et al. Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology 31 (1997) 222-225
90. Mandahl N., Mertens F., Willen H., et al. A new cytogenetic subgroup in lipomas: loss of chromosome 16 material in spindle cell and pleomorphic lipomas. J Cancer Res Clin Oncol 120 (1994) 707-711
91. Shmookler B.M., and Enzinger F.M. Pleomorphic lipoma: a benign tumor simulating liposarcoma. A clinicopathologic analysis of 48 cases. Cancer 47 (1981) 126-133
92. Azzopardi J.G., Iocco J., and Salm R. Pleomorphic lipoma: a tumour simulating liposarcoma. Histopathology 7 (1983) 511-523
93. Meis J.M., and Enzinger F.M. Chondroid lipoma. A unique tumor simulating liposarcoma and myxoid chondrosarcoma. Am J Surg Pathol 17 (1993) 1103-1112
94. Tsutsumi M., Yamauchi A., Tsukamoto S., et al. A case of angiomyolipoma presenting as a huge retroperitoneal mass. Int J Urol 8 (2001) 470-471
95. Meis J.M., and Enzinger F.M. Myolipoma of soft tissue. Am J Surg Pathol 15 (1991) 121-125
96. Furlong M.A., Fanburg-Smith J.C., and Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol 25 (2001) 809-814
97. Gisselsson D., Hoglund M., Mertens F., et al. Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics. Am J Pathol 155 (1999) 61-66
98. Evans H.L., Soule E.H., and Winkelmann R.K. Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of 30 cases formerly classified as well differentiated liposarcoma. Cancer 43 (1979) 574-584
99. Elgar F., and Goldblum J.R. Well-differentiated liposarcoma of the retroperitoneum: a clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation. Mod Pathol 10 (1997) 113-120
100. Lucas D.R., Nascimento A.G., Sanjay B.K., et al. Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol 102 (1994) 677-683
101. Evans H.L. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 3 (1979) 507-523
102. Weiss S.W., and Rao V.K. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation". Am J Surg Pathol 16 (1992) 1051-1058
103. Enzinger F., and Winslow D. Liposarcoma: a study of 103 cases. Virchows Arch Pathol Anat Physiol Klin Med 335 (1962) 367-388
104. Shmookler B.M., and Enzinger F.M. Liposarcoma occurring in children. An analysis of 17 cases and review of the literature. Cancer 52 (1983) 567-574
105. Montgomery E., and Fisher C. Paratesticular liposarcoma; a clinicopathologic study. Am J Surg Pathol 27 (2003) 40-47
106. Montgomery E., and Fisher C. Paratesticular liposarcoma: a clinicopathologic study. Am J Surg Pathol 27 (2003) 40-47
107. Evans H. Liposarcomas and atypical lipomatous tumors: a study of 66 cases followed for a minimum of 10 years. Surg Pathol 1 (1988) 41-54
108. Rosai J., Akerman M., Dal Cin P., et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol 20 (1996) 1182-1189
109. Fletcher C.D., Akerman M., Dal Cin P., et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol 148 (1996) 623-630
110. Azumi N., Curtis J., Kempson R.L., et al. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases. Am J Surg Pathol 11 (1987) 161-183
111. Yoshikawa H., Ueda T., Mori S., et al. Dedifferentiated liposarcoma of the subcutis. Am J Surg Pathol 20 (1996) 1525-1530
112. McCormick D., Mentzel T., Beham A., et al. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. [see comments]. Am J Surg Pathol 18 (1994) 1213-1223
113. Oliveira A.M., Nascimento A.G., Okuno S.H., et al. p27(kip1) protein expression correlates with survival in myxoid and round-cell liposarcoma. J Clin Oncol 18 (2000) 2888-2893
114. Kilpatrick S.E., Doyon J., Choong P.F., et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 77 (1996) 1450-1458
115. Tallini G., Akerman M., Dal Cin P., et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group). Am J Surg Pathol 20 (1996) 1047-1055
116. Spillane A.J., Fisher C., and Thomas J.M. Myxoid liposarcoma-the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol 6 (1999) 389-394
117. Smith T.A., Easley K.A., and Goldblum J.R. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 20 (1996) 171-180
118. Antonescu C.R., Elahi A., Healey J.H., et al. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res 6 (2000) 2788-2793
119. Antonescu C.R., Tschernyavsky S.J., Decuseara R., et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 7 (2001) 3977-3987
120. Sreekantaiah C., Karakousis C.P., Leong S.P., et al. Trisomy 8 as a nonrandom secondary change in myxoid liposarcoma. Cancer Genet Cytogenet 51 (1991) 195-205
121. Paulien S., Turc-Carel C., Dal Cin P., et al. Myxoid liposarcoma with t(12;16) (q13;p11) contains site-specific differences in methylation patterns surrounding a zinc-finger gene mapped to the breakpoint region on chromosome 12. Cancer Res 50 (1990) 7902-7907
122. Newton Jr. W.A., Soule E.H., Hamoudi A.B., et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol 6 (1988) 67-75
123. Cavazzana A.O., Schmidt D., Ninfo V., et al. Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol 16 (1992) 229-235
124. Enzinger F.M., and Shiraki M. Alveolar rhabdomyosarcoma. An analysis of 110 cases. Cancer 24 (1969) 18-31
125. Parham D.M. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14 (2001) 506-514
126. Chen B., Dias P., Jenkins III J.J., et al. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am J Pathol 152 (1998) 1071-1079
127. Sorensen P.H., Lynch J.C., Qualman S.J., et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 20 (2002) 2672-2679
128. Douglass E.C., Rowe S.T., Valentine M., et al. Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 3 (1991) 480-482
129. Barr F.G., Qualman S.J., Macris M.H., et al. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 62 (2002) 4704-4710
130. Douglass E.C., Shapiro D.N., Valentine M., et al. Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 21 (1993) 83-87
131. Shapiro D.N., Sublett J.E., Li B., et al. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53 (1993) 5108-5112
132. Shapiro D.N., Valentine M.B., Sublett J.E., et al. Chromosomal sublocalization of the 2;13 translocation breakpoint in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 4 (1992) 241-249
133. Crist W., Gehan E.A., Ragab A.H., et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13 (1995) 610-630
134. Schurch W., Begin L.R., Seemayer T.A., et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am J Surg Pathol 20 (1996) 131-147
135. Gaffney E.F., Dervan P.A., and Fletcher C.D. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol 17 (1993) 601-609
136. Furlong M.A., Mentzel T., and Fanburg-Smith J.C. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol 14 (2001) 595-603
137. Sonobe H., Takeuchi T., Taguchi T., et al. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin. Int J Oncol 17 (2000) 119-125
138. Das Gupta T.K., Brasfield R.D., Strong E.W., et al. Benign solitary schwannomas (neurilemomas). Cancer 24 (1969) 355-366
139. Antinheimo J., Sankila R., Carpen O., et al. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54 (2000) 71-76
140. Stout A. The peripheral manifestations of specific nerve sheath tumor (neurilemoma). Am J Cancer 24 (1935) 751-796
141. Scheithauer B., Woodruff J.M., and Erlandson R.A. Tumors of the peripheral nervous system (1999), American Registry of Pathology, Washington, DC
142. Ducatman B.S., Scheithauer B.W., Piepgras D.G., et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57 (1986) 2006-2021
143. Kourea H.P., Bilsky M.H., Leung D.H., et al. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer 82 (1998) 2191-2203
144. Sorensen S.A., Mulvihill J.J., and Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314 (1986) 1010-1015
145. Guccion J.G., and Enzinger F.M. Malignant schwannoma associated with von Recklinghausen's neurofibromatosis. Virchows Arch A Pathol Anat Histol 383 (1979) 43-57
146. Daimaru Y., Hashimoto H., and Enjoji M. Malignant peripheral nerve-sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases. Am J Surg Pathol 9 (1985) 434-444
147. deCou J.M., Rao B.N., Parham D.M., et al. Malignant peripheral nerve sheath tumors: the St. Jude Children's Research Hospital experience. Ann Surg Oncol 2 (1995) 524-529
148. Hruban R.H., Shiu M.H., Senie R.T., et al. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 66 (1990) 1253-1265
149. Wong W.W., Hirose T., Scheithauer B.W., et al. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42 (1998) 351-360
150. Lucas D.R., Nascimento A.G., and Sim F.H. Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases. Am J Surg Pathol 16 (1992) 1197-1204
151. Montgomery E., Meis J., Ramos A., et al. Clear cell sarcoma of tendons and aponeuroses. A clinicopathologic study of 58 cases with analysis of prognostic factors. Int J Surg Pathol 1 (1993) 89-100
152. Enzinger F. Clear cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 18 (1965) 1163-1174
153. Chung E.B., and Enzinger F.M. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 7 (1983) 405-413
154. Reeves B.R., Fletcher C.D., and Gusterson B.A. Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet 64 (1992) 101-103
155. Bridge J.A., Sreekantaiah C., Neff J.R., et al. Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer Genet Cytogenet 52 (1991) 101-106
156. Fujimura Y., Ohno T., Siddique H., et al. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene 12 (1996) 159-167
157. Langezaal S.M., Graadt van Roggen J.F., Cleton-Jansen A.M., et al. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 84 (2001) 535-538
158. Mrozek K., Karakousis C.P., Perez-Mesa C., et al. Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer 6 (1993) 249-252
159. Nedoszytko B., Mrozek K., Roszkiewicz A., et al. Clear cell sarcoma of tendons and aponeuroses with t(12;22) (q13;q12) diagnosed initially as malignant melanoma. Cancer Genet Cytogenet 91 (1996) 37-39
160. Zucman J., Delattre O., Desmaze C., et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4 (1993) 341-345
161. Antonescu C.R., Tschernyavsky S.J., Woodruff J.M., et al. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn 4 (2002) 44-52
162. van Ruth S., van Coevorden F., Peterse J.L., et al. Alveolar soft part sarcoma. a report of 15 cases. Eur J Cancer 38 (2002) 1324-1328
163. Lieberman P.H., Brennan M.F., Kimmel M., et al. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 63 (1989) 1-13
164. Evans H.L. Alveolar soft-part sarcoma. A study of 13 typical examples and one with a histologically atypical component. Cancer 55 (1985) 912-917
165. Portera Jr. C.A., Ho V., Patel S.R., et al. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 91 (2001) 585-591
166. Matsuno Y., Mukai K., Itabashi M., et al. Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study of 12 cases. Acta Pathol Jpn 40 (1990) 199-205
167. Auerbach H.E., and Brooks J.J. Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study. Cancer 60 (1987) 66-73
168. Pappo A.S., Parham D.M., Cain A., et al. Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. Med Pediatr Oncol 26 (1996) 81-84
169. Argani P., Lal P., Hutchinson B., et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. Am J Surg Pathol 27 (2003) 750-761
170. Chase D.R., and Enzinger F.M. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol 9 (1985) 241-263
171. Prat J., Woodruff J.M., and Marcove R.C. Epithelioid sarcoma: an analysis of 22 cases indicating the prognostic significance of vascular invasion and regional lymph node metastasis. Cancer 41 (1978) 1472-1487
172. Dabska M., and Koszarowski T. Clinical and pathologic study of aponeurotic (epithelioid) sarcoma. Pathol Annu 17 Pt 1 (1982) 129-153
173. Halling A.C., Wollan P.C., Pritchard D.J., et al. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc 71 (1996) 636-642
174. Ross H.M., Lewis J.J., Woodruff J.M., et al. Epithelioid sarcoma: clinical behavior and prognostic factors of survival. Ann Surg Oncol 4 (1997) 491-495
175. Bos G.D., Pritchard D.J., Reiman H.M., et al. Epithelioid sarcoma. An analysis of fifty-one cases. J Bone Joint Surg Am 70 (1988) 862-870
176. Evans H.L., and Baer S.C. Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases. Semin Diagn Pathol 10 (1993) 286-291
177. Kransdorf M.J. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 164 (1995) 129-134
178. Dardick I., O'Brien P.K., Jeans M.T., et al. Synovial sarcoma arising in an anatomical bursa. Virchows Arch A Pathol Anat Histol 397 (1982) 93-101
179. McKinney C.D., Mills S.E., and Fechner R.E. Intraarticular synovial sarcoma. Am J Surg Pathol 16 (1992) 1017-1020
180. Varela-Duran J., and Enzinger F.M. Calcifying synovial sarcoma. Cancer 50 (1982) 345-352
181. Smith S., Reeves B.R., Wong L., et al. A consistent chromosome translocation in synovial sarcoma. [letter]. Cancer Genet Cytogenet 26 (1987) 179-180
182. Clark J., Rocques P.J., Crew A.J., et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7 (1994) 502-508
183. Coindre J.M., Hostein I., Benhattar J., et al. Malignant peripheral nerve sheath tumors are t(X;18)-negative sarcomas. Molecular analysis of 25 cases occurring in neurofibromatosis type 1 patients, using two different RT-PCR-based methods of detection. Mod Pathol 15 (2002) 589-592
184. van de Rijn M., Barr F.G., Collins M.H., et al. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. Am J Clin Pathol 112 (1999) 43-49
185. Douglass E.C., Rowe S.T., Valentine M., et al. A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet 53 (1990) 87-90
186. Downing J.R., Head D.R., Parham D.M., et al. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol 143 (1993) 1294-1300
187. Sorensen P.H., Lessnick S.L., Lopez-Terrada D., et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6 (1994) 146-151
188. Weidner N., and Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 18 (1994) 486-494
189. Yunis E.J. Ewing's sarcoma and related small round cell neoplasms in children. Am J Surg Pathol 10 Suppl 1 (1986) 54-62
190. Delattre O., Zucman J., Melot T., et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331 (1994) 294-299
191. Dorfman H.D., and Czerniak B. Bone cancers. Cancer 75 (1995) 203-210
192. Huvos A.G. Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer 57 (1986) 1442-1449
193. Raymond A.K., Chawla S.P., Carrasco C.H., et al. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 4 (1987) 212-236
194. Nagarajan R., Clohisy D., and Weigel B. New paradigms for therapy for osteosarcoma. Curr Oncol Rep 7 (2005) 410-414